Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Conmed (CNMD) Short-Term Debt repayments (2016 - 2026)

Conmed filings provide 11 years of Short-Term Debt repayments readings, the most recent being $155.0 million for Q1 2026.

  • On a quarterly basis, Short-Term Debt repayments fell 6.63% to $155.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $684.4 million, a 8.86% decrease, with the full-year FY2025 number at $695.4 million, down 7.65% from a year prior.
  • Short-Term Debt repayments hit $155.0 million in Q1 2026 for Conmed, down from $187.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $230.0 million in Q2 2024 to a low of $92.0 million in Q3 2022.
  • Median Short-Term Debt repayments over the past 5 years was $171.0 million (2025), compared with a mean of $170.2 million.
  • Biggest five-year swings in Short-Term Debt repayments: skyrocketed 139.33% in 2022 and later fell 25.46% in 2025.
  • Conmed's Short-Term Debt repayments stood at $126.0 million in 2022, then surged by 58.73% to $200.0 million in 2023, then fell by 7.0% to $186.0 million in 2024, then increased by 0.54% to $187.0 million in 2025, then dropped by 17.11% to $155.0 million in 2026.
  • The last three reported values for Short-Term Debt repayments were $155.0 million (Q1 2026), $187.0 million (Q4 2025), and $171.0 million (Q3 2025) per Business Quant data.